cagrilintide semaglutide combination phase 3 2024 Updates in Medicine | CagriSema in Adults With or Without Diabetes – REDEFINE 1 & 2 • 💊 2.4 mg + 2.4 mg once weekly • 📉 –20.4% weight Cagrilintide Dosing: 250mcg 3x/Week Protocol

For example, Jessen et al 132 demonstrated that central administration of GLP-1 increased neuronal activity in brain regions (PVN and NTS), thereby mediating autonomic nervous system, as well as activation of HPA axis and stimulation of circulating levels of corticosterone and epinephrine

This emerging metabolic-psychiatry approach offers hope for a population often left without effective options

[PUBMED Abstract] Fizazi K, Azad AA, Matsubara N, et al.: First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial

The injectors could also be made of some biodegradable material that would do much less harm to the environment

Mechanism : Reduces stomach size, curbs hunger hormones like ghrelin, and promotes early satiety

received funding support from the NIH/NIDDK: DK118402